First patient dosed in Phase 1 of ALZ-507 as bio
Author: Michael
With Getlabs acquisition, Function makes health
A widely used add-on therapy could quietly reduc
Women-only wellness brand expands into longevity
Cerevance will present Phase 2 data for Solengepr
Research by SNS Insider values the global longevi
Mesoblast announced that the United States Food a
Eisai Inc.
Avaí Bio announced on 7 April 2026 that it and i
New marketplace aims to bring structure, standar